Parkinson disease (PD), one of the most common neurodegenerative disorder, is believed to be driven by toxic α-synuclein aggregates eventually resulting in selective loss of vulnerable neuron populations, prominent among them, nigrostriatal dopamine (DA) neurons in the lateral substantia nigra (l-SN). How α-synuclein aggregates initiate a pathophysiological cascade selectively in vulnerable neurons is still unclear. Here, we show that the exposure to low nanomolar concentrations of α-synuclein aggregates (i.e. fibrils) but not its monomeric forms acutely and selectively disrupted the electrical pacemaker function of the DA subpopulation most vulnerable in PD. This implies that only dorsolateral striatum projecting l-SN DA neurons were electrically silenced by α-synuclein aggregates, while the activity of neither neighboring DA neurons in medial SN projecting to dorsomedial striatum nor mesolimbic DA neurons in the ventral tegmental area (VTA) were affected. Moreover, we demonstrate functional K-ATP channels comprised of Kir6.2 subunit in DA neurons to be necessary to mediate this acute pacemaker disruption by αsynuclein aggregates. Our study thus identifies a molecularly defined target that quickly translates the presence of α-synuclein aggregates into an immediate impairment of essential neuronal function. This constitutes a novel candidate process how a protein-aggregation-driven sequence in PD is initiated that might eventually lead to selective neurodegeneration.
INTRODUCTION
α-Synuclein is a small 14 kDa protein located mainly in presynaptic terminals, soma and nucleus Ca 2+ entering SN DA neurons might also lead to activation of K-ATP channels thereby facilitating bursting in medial SN DA neurons (Knowlton et al., 2018) . We have previously shown that K-ATP channels, which are composed of inward rectifying K channel subunits (Kir6.2) and sulfonylurea receptors subunits (SUR1) in DA neurons mediate SN DA vulnerability in PD models (Liss et al., 2005) and are necessary for in vivo burst firing in medial DA SN neurons (Schiemann et al., 2012) . However, their functional and potential pathophysiological role in most vulnerable, lateral SN DA neurons is still unknown.
In addition, we have previously shown that mild overexpression of mutant A53T-α-synuclein lead to in vivo hyperactivity of DA SN neurons via oxidative impairment of Kv4.3 channels (Subramaniam et al., 2014) . However, this study focused mostly on the medial SN, where this selective hyperexcitability phenotype of DA SN neurons took more than 6-month in vivo to develop. This study also did not address the question which particular conformer of α-synuclein was responsible. In general, other studies demonstrated that oligomeric/fibrillar α-synuclein is more detrimental to cellular functions in comparison to monomeric α-synuclein, also in DA neurons. For instance, exposure of cultured DA neurons to 100 nM oligomeric α-synuclein for 5-10 minutes was shown to trigger the opening of permeability transition pore and increase oxidative modifications of ATP synthase beta subunit in mitochondria (Ludtmann et al., 2018) . This was in contrast to the monomeric form that increased the activity of ATP synthase to improve the efficiency of ATP production (Ludtmann et al., 2016) .
In summary, it is still unknown whether α-synuclein aggregates induce acute and/or selective functional changes in the most vulnerable, lateral SN DA neurons. In the present study, we demonstrate that these dorso-lateral striatum projecting lateral SN (DLS-lSN) DA neurons respond with an acute disruption of pacemaker firing when challenged with low nanomolar concentrations of α-synuclein fibrils. In contrast, dorso-medial striatum projecting medial SN (DMS-mSN) DA neurons and nucleus accumbens core projecting DA neurons in VTA (NAcC-VTA) maintained their pacemaker function in response to α-synuclein fibrils. Finally, we demonstrate that selective activation of K-ATP channels in DLS-lSN neurons is necessary to mediate this effect of αsynuclein fibrils on electrical activity.
MATERIAL AND METHODS

Identification of various dopamine neuron sub-populations by retrograde tracing
All the experiments were performed on male C57Bl/6N (Charles Rivers) mice aged 8-10 week.
Red fluorescent retrobeads (Lumafluor) were diluted (1:30) in ACSF and stereotaxically injected into brain. Mice were anesthetized by exposure to 4% isoflurane in a closed chamber and maintained at 2-2.5 % level during the surgery. 100 nanoliters of diluted beads were injected 6 bilaterally in either dorso-medial striatum (DMS) (AP-0.74, ML-1.1, DV-2.6); dorso-lateral striatum (DLS) (AP-0.74, ML-2.2, DV-2.6) or nucleus accumbens core (NAcC) (AP-1.54, ML-1.0, DV-4). AP coordinates were adjusted to skull size according to the equation: Final AP coordinate = AP coordinate/4.2*distance (bregma − lambda) + 0.3. Period needed for sufficient labelling of target regions was 3 days for DMS and NAcC, and 2 days for DLS. Examples of injection sites in NAcC, DMS and DLS are shown in figure 1(a).
Electrophysiological patch-clamp recordings
Mice were perfused with ice-cold ACSF (50 mM sucrose, 125 mM NaCl, 2.5 mM KCl, 25 mM NaHCO3, 1.25 mM NaH2PO4, 2.5 mM glucose, 6.2 mM MgCl2, 0.1 mM CaCl2 and 2.96 mM kynurenic acid (Sigma), oxygenated with 95%O2/5%CO2). Mid-brain slices were cut coronally using a vibrating microtome at a thickness of 250 µm and allowed to recover for 50 minutes in oxygenated ACSF (22.5 mM sucrose, 125 mM NaCl, 2.5 mM KCl, 25 mM NaHCO3, 1.25 mM NaH2PO4, 2.5 mM glucose, 2.1 mM MgCl2 and 2 mM CaCl2; 95% O2/5% CO2) at 37 °C.
Recording chamber was continuously perfused with ACSF at a flow rate of 2-4 ml/min. Synaptic input was blocked by addition of CNQX (12.5 µM; Biotrend), D-AP5 (10 µM; Biotrend) and gabazine (SR95531, 4 µM; Biotrend). SN or VTA DA neurons were visualized by infrared differential interference contrast video microscopy. Retrobeads were visualized by epifluorescence (Zeitz, Jena, Germany). Recording pipettes (4-5 MΩ) were fabricated from thin walled borosilicate glass (GC150TF; Harvard Apparatus, Holliston, MA, USA) and filled with internal solution containing 135 mM K-gluconate, 5 mM KCl, 10 mM HEPES, 0.1 mM EGTA, 2 mM MgCl2, 2 mM MgATP, 0.2 mM NaGTP, and 0.1 % neurobiotin, pH 7.4 (285-290 mOsm). Recordings were performed in current clamp or voltage-clamp mode using an EPC-10 patch amplifier (HEKA) with a sampling rate of 10 kHz (low-pass filter, 5 kHz). Electrophysiological data analysis was carried out using custom written scripts in MATLAB_R2017a.
DA neurons containing retrobeads were first recorded in the cell-attached mode to ensure intact pacemaking activity for at least 30 seconds. Afterwards, whole cell configuration was obtained by applying a mild suction. Only neurons with uncompensated series resistance < 10 mOhm were used for analysis. After break in to the whole-cell configuration, recordings in continuous currentclamp were made for a duration of at least 300 seconds to monitor changes in pacemaker function (recordings were carefully terminated via slow conversion to the out-out configuration, which lead to a high success rate (> 95%) of recovering bead-positive, neurobiotin & TH-immunopositive (i.e. DA) neurons post-hoc.
For the extracellular application, 10 nM fibrils were prepared in extracellular solution (0.5 M NaCl, 10 mM HEPES buffer, pH 7.49). Recording pipettes (9-10 MΩ) were fabricated from thick walled borosilicate glass (GC150TF; Harvard Apparatus, Holliston, MA, USA and filled with regular internal solution as described before. After giga-seals were obtained, pacemaker firing was recorded in the voltage clamp mode without breaking into the cell. Once regular firing was observed for at least 30 seconds, extracellular solution (either control or with 10 nM fibrils) was puffed on the cell being recorded using a second pipette with mild pressure (30-50 mbar) so that seal was not disturbed. Recordings were continued for at least 30 seconds post-application of control or 10 nM fibril containing extracellular solution.
After recording, patch slices were post-fixed in 4% paraformaldehyde in PBS, pH 7.4. Striatal regions containing injection sites for retrobeads were also post-fixed and cut at 50 µm thickness for IHC.
Intracellular dialysis of monomeric and fibrillar α-synuclein into DA neurons
Recombinant human wild type α-synuclein monomeric protein was purified from E.coli and assembled into fibrils at 5mg/mL in PBS (pH-7.0) for 7 days as described previously (Volpicelli-Daley et al., 2014) . Fibrillization was confirmed using multiple methods ( Fig. S1 ). Aliquots of each reaction tube were centrifuged (45,000 x g, 30 minutes at 23°C) and separated on a 15% SDS gel. Gel was then stained with Coomassie Brilliant Blue and scanned by LiCor (Fig. S1a ). The same samples were also assessed using Thioflavin T absorbance assay to confirm amyloid formation ( Fig. S1b ). To verify their pathogenic potential, 200 nM fibrils were added to mouse hippocampal neurons from embryonic day 16-18 CD1 mice. Neurons were cultured for seven days in poly-D-lysine coated 96-well plates prior to transduction with fibrils and were fixed twelve days post-transduction and stained with 81A antibody to assess the presence of aggregates ( Fig. S1c ).
For electrophysiology experiments, fibrils and monomers were dissolved in sterile dPBS to a stock concentration of 1.25 µg/µl (89.3 µM). 5 µl of this stock solution was diluted with 887 µl of dPBS to obtain an intermediate concentration of 0.5 µM and stored at -80°C. On the day of experiment, to obtain a final concentration of 10 nM, 20 µl of intermediate stock was diluted with 980 µl internal pipette solution (see above) to obtain a final volume of 1 ml. The final solution was sonicated using a Q-sonica probe sonicator (20% power) for 1 minute in a pulsed manner to break down the bigger aggregates of α-synuclein. Monomeric α-synuclein was also prepared in a similar manner but was not sonicated. Control pipette solution was diluted with equivalent amount of dPBS. Final dilution step for both fibrillar and monomeric α-synuclein was carried out immediately before experiment and made fresh for each day of experiment. This approach allowed a targeted application of α-synuclein in each cell.
It should be noted that the molarity calculation is made using the molecular weight of 14 kDa for monomeric α-synuclein. Real molarity of fibrillar solution is expected to be lower than this because of higher molecular weight. However, sonication step leads to a heterogenous mixture with filament sizes usually ranging from 30 nm to 100nm as described previously (Luk et al., 2012; Polinski et al., 2018) . Therefore, it is not possible to ascertain the exact molecular weight and molarity of this solution. Addition of monomeric α-synuclein did not cause any change in osmolarity of internal solution (likely due to extremely small concentration). Osmolarity of fibrillar α-synuclein solution could not be measured as the instrument is unable to detect osmolarity in a self-aggregating solution.
Immunohistochemistry and confocal analysis
Free floating sections were rinsed in PBS and incubated in blocking solution (0.2 M PBS with 10% horse serum, 0.5% Triton X-100, 0.2% BSA). Sections were incubated overnight (room temperature) with goat anti tyrosine hydroxylase (1:1000, Calbiochem/ Merck) antibody diluted in the carrier solution (0.2 M PBS with 1% horse serum, 0.5% Triton X-100, 0.2% BSA). After rinsing with PBS, sections were incubated with goat anti-rabbit Alexa Flour 405 (1:750, Invitrogen). To detect the neurobiotin, streptavidin AlexaFluor-488 (1:1000, Invitrogen) was used.
After final rinsing with PBS, sections were mounted on slides with fluorescent mounting medium (Vectashield, Vector Laboratories), coverslipped and visualized with confocal microscope (Nikon Eclipse90i, Nikon GmbH). Location of each recorded neuron was documented and manually reconstructed using the mouse brain atlas (Paxinos and Watson, 2007) as a reference map.
Statistical analysis
All the statistical tests were performed using GraphPad Prism 7 (GraphPad Software, Inc., La Jolla, CA, USA). Values are given as mean ± sem. One-way ANOVA with Holm Sidak's post-hoc correction was applied to compare the groups for all analysis unless specified. P values less than 0.05 were considered significant.
RESULTS
Nanomolar alpha-synuclein fibrils but not monomers disrupt pacemaker firing of vulnerable dopamine neurons.
All the recorded midbrain neurons were identified based on their axon projection targets in dorsal or ventral striatum and were immuno-positive for TH (i.e. were DAergic). Figure 1a shows the representative injection sites for fluorescent retro beads in distinct regions of striatum and nucleus accumbens. Neurons were selected for electrophysiological recordings based on the presence of fluorescent beads and filled with neurobiotin during the recording. As shown in Figure 1b , expression of TH was documented in neurobiotin-and beads-labelled cells. Anatomical location of all recorded neurons was mapped according to the mouse brain atlas (Fig 1c) . (Fig. 2c ). In the presence of synaptic blockers, we monitored spontaneous activity in the on-cell mode to exclude recording from DA neurons damaged by the slice preparation. Shortly after breaking into the whole cell configuration, we switched to current-clamp and monitored spontaneous electrical activity for at least 300 seconds. Figure 2 shows the effect of dialyzing 10 nM of α-synuclein fibrils into a DLS-lSN DA neuron via the patch pipette. In contrast to recordings of DLS-lSN DA neurons with control pipette solutions, which showed stable (with some degree of slowing), regular and continuous pacemaking, DLS-lSN neurons that were patched with pipette solution containing 10 nM α-synuclein fibrils displayed a dramatic, about 90% decrease in pacemaker frequency within 5 minutes ( Fig. 2d ). Overall, there was a significant (p< 0.01) decline in steady state firing rate (i.e. firing rate in last 10 seconds of recording) in neurons dialyzed with fibrils in comparison to neurons filled with control recording solution.
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The frequency reduction was accompanied by a significant increase (p< 0.01) in firing irregularity (quantified as coefficient of variation (CV) of inter-spike intervals; Fig. 2g ) in comparison to controls. On the other hand, DLS-lSN DA neurons recorded with 10 nM monomeric α-synuclein showed no loss of firing frequency or regularity ( Fig. 2d, 2f, 2g ), in comparison to control solution.
In about 65% (n = 9/14) DLS-lSN DA neurons dialyzed with 10 nM α-synuclein fibrils, the spontaneous activity was completely abolished (Fig. 2f ) with the membrane potential persistently hyperpolarizing below the threshold for pacemaking ( Fig. 2e, 2h) . In contrast to neurons exposed to fibrillar α-synuclein, only 25% DLS-lSN neurons (n=3/12) exposed to monomeric α-synuclein ceased their spontaneous activity ( Fig. 2f ) and showed hyperpolarization of the average membrane potential (Fig. 2h) . Indeed, steady state membrane potentials (i.e. membrane average potential in last 10 seconds of recording) were significantly lower in neurons dialyzed with fibrils (p< 0.05) compared to controls and monomers.
As additional controls, we also performed experiments with extracellular exposure to 10 nM αsynuclein fibrils while monitoring firing activity in the on-cell mode. Importantly, we observed that DLS-lSN DA neurons also ceased to fire after local extracellular application of 10nM fibrils but not when control extracellular solution were applied (Fig. S2a, S2b) . Also, in on-cell, where the metabolic integrity of the neurons is unperturbed, there was a significant decrease in average firing frequency and increase in CV after extracellular application of fibrils (Fig. S2c, S2d) . These experiments essentially rule out that the selective effect of α-synuclein fibrils on DLS-lSN DA was an artifact induced or potentiated by the whole-cell configuration. Figure 3 shows the firing patterns of mSN DA neurons projecting to dorso-medial striatum in mice.
In humans, the most equivalent dorso-medial DA projection would innervate the caudate nucleus, which is less affected in PD. In contrast to the DLS-lSN DA neurons, DMS-mSN DA neurons displayed no loss of pacemaker firing (Fig. 3d, 3f ) or membrane hyperpolarization (Fig. 3e, 3h) after dialysis of either 10 nM fibrils or monomers. There was an only about 30% decrease in pacemaker firing frequency after exposure to both fibrillar or monomeric α-synuclein, which was very similar to the about 22% decrease in average firing frequency in control experiments. Some DMS-mSN DA neurons (n=5/11) displayed an increased variability in firing as shown in the trace in figure 3b. This lead to an increase in CV of these neurons, but overall it was not statistically different from the neurons in control group (Fig. 3g) . None of the neurons exposed to monomeric α-synuclein displayed any irregularity in pacemaker firing or a decrease in steady state membrane potential. Consistent with their smaller susceptibility during PD, DMS-mSN DA neurons responded -if at all -only weakly to fibrils. Figure 4 shows the firing patterns of VTA DA neurons projecting to ventral striatum, more particularly, the core of nucleus accumbens, which is only mildly affected in PD. There was no significant change in the frequency of firing (Fig. 4d, 4f ) or the regularity of firing (Fig. 4g ) of these mesolimbic DA neurons in presence of either 10 nM α-synuclein fibrils or monomers.
Further, no changes in the average membrane potential were observed in neurons recorded with fibrillar or monomeric α-synuclein ( Fig. 4e, 4h ). Overall DLS-lSN DA neurons were most severely affected by exposure to fibrillar α-synuclein in comparison to the other two DA subpopulations.
K-ATP channel activation in DA neurons mediates the disruption of firing patterns by fibrillar α-synuclein
Next, we asked whether K-ATP channel activation mediates the α-synuclein fibril induced membrane hyperpolarization and loss of firing activity. We recorded DLS-lSN DA neurons with α-synuclein fibrils in the presence of the K-ATP channel inhibitor glibenclamide (1µM) in the bath solution. Prior to the application of glibenclamide, we observed an 80% decrease in firing frequency as well as membrane hyperpolarization in response to nanomolar α-synuclein fibrils ( Fig. 5b, 5d ). Similar to previously described changes (Fig. 2) , complete cessation of pacemaker firing was observed in around 67% of recorded neurons (n=8/12) leading to a significant decrease in steady state firing frequency in comparison to control (p< 0.001). In contrast, after application of glibenclamide, DLS-lSN DA neurons continued to fire despite the presence of α-synuclein fibrils ( Fig. 5c ) and showed only 19% decrease in firing rate over the recording period. Steady state firing frequency of these neurons was significantly higher in comparison to the neurons treated with only fibrils (p< 0.001) (Fig. 5f ). Some recordings were also obtained with control solution in patch pipette and glibenclamide in the bath (Fig. 5a ). In this case, we observed a higher firing frequency (initial frequency around 4.5 Hz) compared to the DLS-lSN neurons recorded regularly with a control solution (initial frequency around 3 Hz) indicating the K-ATP channels were already partially active in this DA subpopulation. This was also supported by on-cell firing frequency data (data not shown). Average firing frequency of glibenclamide-treated control cells (4.8 ± 0.15 Hz, n=11) was significantly higher (p<0.001, unpaired t-test) than the control cells without glibenclamide (3.2 ± 0.3 Hz, n=13). Figure 5f compares steady state firing frequencies between the different groups demonstrating significantly higher frequencies in fibrils treated neurons in the presence of glibenclamide as compared to those without glibenclamide (p< 0.001,). Also, fibril-induced increases in CV in comparison to control (p< 0.001) was also not observed after application of glibenclamide. Most importantly, glibenclamide treatment was able to prevent the time dependent membrane hyperpolarization observed in the presence of fibrils (Fig. 5e, 5h ). There was a significant increase in steady state average membrane potential in the neurons treated with glibenclamide and fibrils both in comparison to the ones treated with only fibrils (p< 0.01).
In summary, pharmacological experiments identified functional K-ATP channels in DA neurons as a necessary mediator for the α-synuclein fibrils-induced disruptions of pacemaking in DLS-lSN DA neurons.
DISCUSSION
The exceptionally high susceptibility of DA neurons in the lateral SN to degenerate during PD in comparison to more medial DA SN and VTA neurons has been well-documented (Fearnley and Lees, 1991; Kordower et al., 2013b) but the underlying pathophysiological mechanisms have remained unclear. In essence, it was unknown whether these most vulnerable DA midbrain neurons responded to α-synuclein aggregates in a particular and selective fashion. By studying changes in pacemaker firing patterns of well-defined DLS projecting (putamen-equivalent in primates) lSN DA neurons and DMS projecting (caudate-equivalent in primates) mSN DA neurons subpopulations, we have now identified differential functional responses of these two DA subpopulations after acute exposure to α-synuclein fibrils. Only the most vulnerable DA neurons in the lateral SN showed acute impairment and even silencing of their cell-autonomous pacemaker activity in response to exposure to α-synuclein fibrils in low nanomolar concentrations. Our work targeted a highly relevant cellular population lost in PD and identified a dramatic pathophysiological response with high selectivity and exquisite sensitivity.
Several previous studies have reported the pathophysiological responses to α-synuclein in DA and non-DA neurons (for review, see (Thakur et al., 2019) ). For instance, Wu and colleagues have shown that in the primary hippocampal neurons, the fibrillar form of α-synuclein but not the monomeric form lead to decreased synaptic activity in a time-and dose-dependent manner (Wu et al., 2019) . Further, incubation with 500 nM α-synuclein oligomers have also been observed to inhibit long-term potentiation in hippocampal brain slices (Martin et al., 2012; Ferreira et al., 2017) . Dialyzing 500 nM α-synuclein oligomers through a patch pipette -a similar approach like in our study -into layer 5 cortical pyramidal neurons induced a drop in input resistance and in turn reduced excitability (Kaufmann et al., 2016) . In addition, increase in action potential durations were found to be specific to oligomeric but not monomeric α-synuclein (Kaufmann et al., 2016) . However, the relevant ion channels were not identified in these types of studies.
In contrast, we identified here a causal role for K-ATP channels selectively in DLS-lSN DA neurons for fibrillar α-synuclein-induced impairment of pacemaking, a key feature of DA neuronal functioning. We have previously shown that K-ATP channels in DA SN but not DA VTA neurons are also sensitive response elements to nanomolar concentrations of rotenone, a mitochondrial complex I inhibitor (Röper and Ashcroft, 1995; Liss et al., 1999 Liss et al., , 2005 . Moreover, we showed that the rotenone-induced K-ATP channel activation in DA SN neurons was mediated by mitochondrially generated redox stress (Liss et al. 2005) . Although this study did not yet differentiate between medial and lateral DA SN neurons, it might imply that also fibrillar αsynuclein activate K-ATP channels via redox signaling, but more studies are needed to test this possibility explicitly. There is however evidence, that fibrillar α-synuclein increase oxidative stress by several, converging mechanisms including mitochondrial dysfunction and altered calcium handling, potentially also acting on a fast time scale and in the low nanomolar range (Choi et al., 2012; Luth et al., 2014; Deas et al., 2015; Thakur et al., 2019) .
Also, our study cannot establish the immediate functional impact of α-synuclein mediated K-ATP channel activation in vivo. While our in vitro data suggest also an acute impairment of DLS-lSN DA neurons (see (Farassat et al., 2019) for functional in vivo properties DLS-lSN DA neurons), our previous in vivo study on K-ATP channels in DA SN neurons suggest that their activation - show a drastic increase in irregularity after fibrils wash-in but not in monomers when compared to control. h Comparison of steady state membrane potential (i.e. membrane potential during last 10 seconds of recording) also shows a significant decline (Ordinary one-way ANOVA followed by Holm Sidak's multiple comparison test) in membrane potential after fibrils wash-in in comparison to control. All data is represented as mean ± sem. Control-n=13, N=9; Fibrils-n=14, N=3;
Monomers-n=12, N=3, where n= number of neurons, N= number of mouse. treatement. e Glib application resulted in an increased average membrane potential even in the presence of fibrils. f There was a significant decline in steady state firing frequency (p< 0.001, Ordinary one-way ANOVA followed by Holm Sidak's multiple comparison test) and g increase in firing variability (p< 0.001, Ordinary one-way ANOVA followed by Holm Sidak's multiple 22 comparison test) in presence of α-synuclein fibrils, which was prevented in presence of Glibenclamide. h Wash-in of Glibenclamide also prevents the hyperpolarization of membrane potential observed after α-synuclein fibrils treatment (p< 0.001, Ordinary one-way ANOVA followed by Holm Sidak's multiple comparison test). All data is represented as mean ± sem.
Control+Glib-n=11, N=4; Fibrils-n=12, N=4; Fibrils+Glib-n=15, N=3, where n= number of neurons, N= number of mouse. 
